Laporan Laba Rugi SUPN - TTM - Supernus Pharmaceuticals, Inc.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Supernus Pharmaceuticals, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	477	520	556	571	564	580	601	630	659	667	668	634	611	608	597	630	652	662	668	665
Change (%)		9.03	6.91	2.62	-1.17	2.75	3.72	4.78	4.59	1.26	0.19	-5.16	-3.70	-0.49	-1.67	5.48	3.46	1.51	0.93	-0.43
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	38	52	63	80	77	75	78	73	81	87	93	93	87	84	77	73	71	78	77	76
Change (%)		37.91	20.59	26.31	-4.13	-2.01	3.97	-5.86	10.61	7.33	6.34	0.68	-6.72	-3.82	-8.54	-4.14	-2.75	9.06	-0.70	-1.41
% of Revenue	7.97	10.08	11.37	13.99	13.57	12.95	12.98	11.66	12.33	13.07	13.87	14.73	14.27	13.79	12.83	11.66	10.96	11.77	11.58	11.47

Gross Operating Profit	439	468	493	491	488	505	523	557	578	580	576	541	523	524	521	557	581	584	591	589
Change (%)		6.53	5.38	-0.41	-0.69	3.49	3.68	6.36	3.79	0.40	-0.74	-6.10	-3.18	0.06	-0.57	6.90	4.28	0.58	1.15	-0.30
% of Revenue	92.03	89.92	88.63	86.01	86.43	87.05	87.02	88.34	87.67	86.93	86.13	85.27	85.73	86.21	87.17	88.34	89.04	88.23	88.42	88.53

SG&A	177	201	212	234	251	305	334	365	405	377	372	359	329	336	337	336	335	336	344	352
Change (%)		13.41	5.70	10.10	7.52	21.36	9.52	9.27	11.05	-6.86	-1.29	-3.68	-8.26	2.22	0.27	-0.26	-0.28	0.10	2.33	2.52
% of Revenue	37.07	38.56	38.13	40.91	44.50	52.57	55.50	57.88	61.46	56.53	55.70	56.57	53.90	55.37	56.46	53.38	51.45	50.74	51.44	52.96

R&D	78	76	91	85	87	90	77	78	78	75	75	83	86	92	95	97	103	109	111	107
Change (%)		-2.38	20.20	-7.44	3.33	3.60	-14.86	1.21	-0.13	-4.24	0.50	10.67	3.74	6.48	4.06	1.89	6.57	5.12	1.84	-3.67
% of Revenue	16.30	14.60	16.41	14.80	15.48	15.60	12.81	12.37	11.81	11.17	11.21	13.08	14.09	15.08	15.95	15.41	15.87	16.44	16.59	16.05

OpEx	304	345	387	422	439	500	533	575	638	622	622	616	584	594	592	590	591	600	609	614
Change (%)		13.47	12.28	8.99	4.03	13.98	6.63	7.87	10.88	-2.58	0.06	-0.90	-5.22	1.70	-0.39	-0.38	0.28	1.57	1.49	0.69
% of Revenue	63.67	66.26	69.58	73.90	77.78	86.29	88.71	91.33	96.83	93.16	93.04	97.22	95.69	97.79	99.06	93.55	90.68	90.73	91.23	92.25

Operating Income	173	176	169	149	125	79	68	55	21	46	47	18	26	13	6	41	61	61	59	52
Change (%)		1.26	-3.63	-11.93	-15.87	-36.59	-14.59	-19.55	-61.73	118.23	1.97	-62.11	49.47	-49.12	-58.02	622.31	49.58	0.94	-4.48	-12.07
% of Revenue	36.33	33.74	30.42	26.10	22.22	13.71	11.29	8.67	3.17	6.84	6.96	2.78	4.31	2.21	0.94	6.45	9.32	9.27	8.77	7.75

Interest Expense	-23	-24	-24	-24	-24	-23	-19	-16	-11	-7	-7	-6	-4	-2	-3	0	0
Change (%)		1.36	1.44	-1.44	-0.69	-0.69	-17.74	-18.98	-26.91	-38.04	-6.18	-13.57	-30.07	-39.76	18.43	-100.00	NaN
% of Revenue	-4.91	-4.56	-4.33	-4.16	-4.18	-4.04	-3.20	-2.48	-1.73	-1.06	-0.99	-0.90	-0.66	-0.40	-0.48	0.00	0.00

Net Income	129	127	111	100	82	53	73	57	38	61	52	43	26	1	-16	5	60	74	62	64
Change (%)		-1.83	-12.46	-9.85	-18.40	-34.65	37.29	-21.62	-34.47	61.16	-14.28	-16.71	-40.89	-94.86	-1,278.42	-133.78	1,039.76	23.70	-16.18	4.17
% of Revenue	27.09	24.39	19.97	17.55	14.49	9.21	12.20	9.12	5.72	9.10	7.79	6.84	4.20	0.22	-2.60	0.83	9.16	11.16	9.27	9.70

Source: Capital IQ

Supernus Pharmaceuticals, Inc. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)

Other Listings

DE:S49	€ 39.00
GB:0LB2